Dose-Finding Study of E7070 in Combination With Irinotecan
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
E7070 and irinotecan will be administered to patients with GI tract, pancreatic or lung
tumors on Days 1 and 8 of a 21-day cycle, or Days 1 and 15 of a 28-day cycle according to one
of two E7070 dose escalation schemes.